OpenBind: AI Drug Discovery Dataset & Model Released

A UK-led initiative called OpenBind just released its first public dataset and AI model for drug discovery. This is a huge step forward in using artificial intelligence to find new medicines. Here's the thing: while AI has been great for predicting protein structures, it's been limited in drug discovery because there simply isn't enough reliable experimental data. OpenBind aims to fix this. What's interesting is that this collaboration, led by Diamond Light Source, has generated 800 high-quality measurements in just seven months. Before, this kind of data took years to produce. They're combining automated chemistry and advanced crystallography with AI model training. The bottom line: This new release makes high-quality data and a predictive AI model, called OpenBind v1, freely available to researchers. This will accelerate the discovery of new treatments for diseases like COVID-19, malaria, dengue, Zika, and cancer.